| Financial Year |
March 31 2023 |
| Monetary Funds |
5,169,120,798.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
258,309,055.93 |
| Accounts Receivable |
3,334,979,949.40 |
| Advances to Suppliers |
91,769,538.44 |
| Other Receivables |
485,849,451.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,064,560.87 |
| Dividend Receivable |
138,084,174.58 |
| Inventories |
124,883,302.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,250,000.00 |
| Other Current Assets |
363,191,539.38 |
| Total Current Assets |
9,982,387,914.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,755,534,855.95 |
| Investment Properties |
165,724,354.07 |
| Fixed Assetes |
30,297,125,564.20 |
| Under-construction Projects |
2,248,757,352.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,445,986,603.50 |
| R&D expenses |
12,684,691.00 |
| Goodwill |
225,929,504.67 |
| Long-Term Deferred and Prepaid Expenses |
54,541,149.56 |
| Deferred Income Tax Assets |
311,407,055.12 |
| Other Non-Current Assets |
12,321,742.03 |
| Sub-Total of Non-Current Assets |
47,600,939,879.50 |
| Total Assets |
57,583,327,793.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
256,952,442.32 |
| Accounts Received In Advance |
3,717,343.06 |
| Employee Compensation Payable |
196,725,691.82 |
| Taxes Payable |
167,997,509.25 |
| Interest Payable |
-- |
| Dividend Payable |
129,642,029.96 |
| Other payables |
747,248,073.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,498,781,465.77 |
| Other Current Liabilities |
11,209,159.97 |
| Sub-Total of Current Liabilities |
6,060,156,484.96 |
| Long-term Loans |
716,000,000.00 |
| Bonds Payable |
2,496,531,096.61 |
| Long-Term Accounts Payable |
17,500,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
166,568,538.56 |
| Deferred Income Tax Liabilities |
252,392,151.21 |
| Other Non-Current Liabilities |
41,606,945.81 |
| Sub-Total of Non-Current Liabilities |
9,328,137,273.41 |
| Total Liabilities |
15,388,293,758.37 |
| Paid-In Capital(Or Share Stock) |
23,987,065,816.00 |
| Capital Surplus |
9,028,653,533.25 |
| Surplus Reserve |
1,462,397,659.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,342,144,399.66 |
| Minority Stockholder's Interest |
3,139,053,657.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,055,980,378.40 |
| Owner's Equity（Stockholder's Equity） |
42,195,034,035.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
57,583,327,793.86 |
